Recombinant Human DNase (rhDNase) in Cystic Fibrosis: Is It Cost Effective?

Archives of Disease in Childhood - United Kingdom
doi 10.1136/adc.77.1.1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Human Papillomavirus Vaccination: Is It Cost-Effective in Iran?

Journal of Obstetrics, Gynecology and Cancer Research
2017English

A Multinational Economic Evaluation of rhDNase in the Treatment of Cystic Fibrosis

International Journal of Technology Assessment in Health Care
Health Policy
1996English

The Effects of Recombinant Human DNase on Neutrophil Elastase Activity and Interleukin-8 Levels in the Sputum of Patients With Cystic Fibrosis

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1996English

Contingency Management Works, Clients Like It, and It Is Cost-Effective

American Journal of Drug and Alcohol Abuse
MedicineClinical PsychologyPsychiatryMental Health
2016English

Control of Vancomycin-Resistant Enterococci: It Is Important, It Is Possible, and It Is Cost-Effective

Infection Control and Hospital Epidemiology
EpidemiologyInfectious DiseasesMicrobiology
2002English

Dexamethasone Implant for Non-Infectious Uveitis: Is It Cost-Effective?

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2019English

Is Cystic Fibrosis Mucus Abnormal?

Pediatric Research
Child HealthPediatricsPerinatology
1981English

Jejunoileal Atresia and Cystic Fibrosis: Don’t Miss It

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2012English

Cost-Effectiveness of Carrier Screening for Cystic Fibrosis in Australia

Journal of Cystic Fibrosis
Child HealthPulmonaryPediatricsPerinatologyRespiratory Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy